GGPOKER
The World Series of Poker (WSOP) and GGPoker today announce a comprehensive schedule of online WSOP events kicking off with the WSOP Super Circuit Online Series on Saturday, May 1 and WSOP Online 2021 International tournament starting Sunday, Aug 1. Events open to international players will be hosted on the GGPoker app, while US players will enter via the WSOP.com online poker platform.
2021 WSOP Events at GGPoker and WSOP.com:
- WSOP Super Circuit Online Series at GGPoker - May 1-May 30
- WSOP Online 2021 (Domestic US) at WSOP.com - July 1-Aug. 1
- WSOP Online 2021 at GGPoker (International) - Aug. 1-Sept. 12
- WSOP Las Vegas “Main Event” satellites - Aug. 1-Oct. 1
- WSOP Winter Online Super Circuit at GGPoker - Dates TBC
WSOP action kicks off at GGPoker with the $100 million-guaranteed WSOP Super Circuit Online Series, scheduled from May 1 through May 30. A total of 18 WSOP Circuit ring events will headline the series, with a coveted WSOP Circuit gold ring awarded to each tournament’s winner. Furthermore, for the first time, an additional two WSOP Circuit rings will be awarded to cash game specialists; No-Limit Hold’em and Pot-Limit Omaha/Pot Limit Omaha-5 leaderboards will determine the invitation list for these two final-table-only events.
Dozens of WSOP gold bracelets will be up for grabs in the previously-announced WSOP 2021 Online series, which runs on WSOP.com for US players from July 1 through Aug. 1 and at GGPoker for international players from Aug. 1 through Sept. 12. A total of 33 bracelets will be won on WSOP.com, with the same number of bracelet tournaments at GGPoker. Last year’s WSOP Online Main Event at GGPoker was awarded the Guinness World Record for the largest prize pool in a single online poker tournament, boasting a massive $27.5 million in prizes.
Online satellite tournaments awarding tickets to the live World Series of Poker $10,000 No-Limit Hold’em World Championship, better known as “The Main Event®”, will also be hosted on WSOP.com and at GGPoker beginning Aug. 1. “The Main Event” is expected to begin on Nov. 4 in Las Vegas at the Rio All-Suite Hotel & Casino, and is the most famous live poker event on the planet. It has been held annually since 1970 and draws thousands of players from more than 100 countries, creating poker history with each new champion.
GGPoker will also host the WSOP Winter Online Super Circuit later in the year, with dates to be confirmed.
“The bar has been set with last year’s record-breaking series, but we’re hoping to raise it even higher this year,” said Gregory Chochon, Director of the World Series of Poker. “One of our goals is to provide as many people the chance to become champions as possible. However, we know not everyone can or is comfortable traveling yet, so continuing a robust online bracelet offering in 2021 is a must.”
Added GGPoker Head of Poker Operations Steve Preiss, “When GGPoker & WSOP partnered in 2020, we broke world records. Our plans for 2021 are to offer even more to our customers. With massive tournaments, WSOP gold bracelets & rings, and a route into the live WSOP Main Event in November, we hope players will love what we have in store for them.”
Full details on all online WSOP events will be released over the coming weeks and months, and will include tournament dates, buy-ins and other important information.
New GGPoker players are eligible to claim the poker room’s Welcome Bonus, earn additional rewards with the Honeymoon for Newcomers promotion and automatically join GGPoker’s Fish Buffet loyalty program, with regular cash prizes on offer.
For more information on the WSOP Super Circuit Online Series, please visit: https://en.ggpoker.com/tournaments/wsop-super-circuit-online-series/
About GGPoker : GGPoker is one of the world’s leading online poker rooms, with a global player base. It offers a range of innovative games and features such as the patented Rush & Cash poker, All-In or Fold, Flip & Go, Spin & Gold, integrated staking platform, SnapCam video messaging, the ability to squeeze your hole cards, PokerCraft, and Smart HUD, all designed to enhance gaming experiences and make poker more fun than ever. In 2020, GGPoker hosted WSOP tournaments, including the world record-breaking WSOP Online main event and the WSOP 2020 Main Event, while in April 2021, GGPoker hosts the $150M-guaranteed GG Spring Festival.
Find out more about GGPoker at GGPoker.com and on Facebook and Twitter .
About the World Series of Poker : The World Series of Poker® is the largest, richest and most prestigious gaming event in the world, having awarded more than $3.29 billion in prize money and the prestigious gold bracelet, globally recognized as the sport’s top prize. Featuring a comprehensive slate of tournaments in every major poker variation, the WSOP is poker’s longest-running tournament in the world, dating back to 1970. In 2019, the event attracted 187,298 entrants from 118 different countries to the Rio All-Suite Hotel & Casino in Las Vegas and awarded more than $293 million in prize money. In addition, the WSOP has formed groundbreaking alliances in broadcasting, digital media and corporate sponsorships, while successfully expanding the brand internationally with the advent of WSOP Europe in 2007 and the WSOP Asia-Pacific in 2013 and the WSOP International Circuit Series in 2015. For more information on the WSOP, please visit www.wsop.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210426005638/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom